Status:

COMPLETED

Computer-Assisted Rehabilitation Environment Training After Argus Retinal Prosthesis

Lead Sponsor:

The Cleveland Clinic

Conditions:

Retinitis Pigmentosa

Eligibility:

All Genders

25-100 years

Phase:

NA

Brief Summary

The goal of the current project is to fill the unmet clinical needs around the objective assessment of visual function and develop outcome-oriented visual rehabilitation approach using the computer as...

Eligibility Criteria

Inclusion

  • Recipient of the Argus II Retinal Prosthesis System
  • Ability to provide informed consent
  • Ability to follow two-step commands
  • Ability to ambulate 300+ feet with or without visual assistance
  • Able to tolerate Argus device turned on for \>20 continuous minutes.

Exclusion

  • Dementia
  • Musculoskeletal contraindication to exercise or walking
  • Cardiopulmonary contraindication exercise (i.e. uncontrolled heart failure, cardiac arrhythmia, or pulmonary disease).

Key Trial Info

Start Date :

January 30 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 20 2018

Estimated Enrollment :

4 Patients enrolled

Trial Details

Trial ID

NCT03444961

Start Date

January 30 2018

End Date

June 20 2018

Last Update

July 14 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cleveland Clinic

Cleveland, Ohio, United States, 44195